全文获取类型
收费全文 | 1887篇 |
免费 | 162篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 149篇 |
妇产科学 | 60篇 |
基础医学 | 237篇 |
口腔科学 | 56篇 |
临床医学 | 213篇 |
内科学 | 343篇 |
皮肤病学 | 66篇 |
神经病学 | 200篇 |
特种医学 | 23篇 |
外科学 | 208篇 |
综合类 | 21篇 |
一般理论 | 1篇 |
预防医学 | 176篇 |
眼科学 | 15篇 |
药学 | 123篇 |
中国医学 | 2篇 |
肿瘤学 | 136篇 |
出版年
2023年 | 19篇 |
2022年 | 6篇 |
2021年 | 49篇 |
2020年 | 48篇 |
2019年 | 52篇 |
2018年 | 70篇 |
2017年 | 44篇 |
2016年 | 55篇 |
2015年 | 56篇 |
2014年 | 70篇 |
2013年 | 94篇 |
2012年 | 124篇 |
2011年 | 129篇 |
2010年 | 70篇 |
2009年 | 69篇 |
2008年 | 133篇 |
2007年 | 131篇 |
2006年 | 105篇 |
2005年 | 105篇 |
2004年 | 94篇 |
2003年 | 84篇 |
2002年 | 65篇 |
2001年 | 39篇 |
2000年 | 33篇 |
1999年 | 33篇 |
1998年 | 25篇 |
1997年 | 11篇 |
1996年 | 11篇 |
1995年 | 5篇 |
1994年 | 8篇 |
1993年 | 5篇 |
1992年 | 21篇 |
1991年 | 27篇 |
1990年 | 19篇 |
1989年 | 15篇 |
1988年 | 14篇 |
1987年 | 11篇 |
1986年 | 12篇 |
1985年 | 10篇 |
1984年 | 12篇 |
1983年 | 9篇 |
1982年 | 5篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1976年 | 4篇 |
1974年 | 9篇 |
1973年 | 4篇 |
1972年 | 4篇 |
1971年 | 4篇 |
1967年 | 3篇 |
排序方式: 共有2055条查询结果,搜索用时 31 毫秒
1.
Thomas Fuchs-Buder Sorin J. Brull Malin Jonsson Fagerlund J. Ross Renew Guy Cammu Glenn S. Murphy Michiel Warlé Matias Vested Béla Fülesdi Reka Nemes Malachy O. Columb Daniela Damian Peter J. Davis Hajime Iwasaki Lars I. Eriksson 《Acta anaesthesiologica Scandinavica》2023,67(8):994-1017
The set of guidelines for good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents was developed following an international consensus conference in Copenhagen in 1996 (Viby-Mogensen et al., Acta Anaesthesiol Scand 1996, 40 , 59–74); the guidelines were later revised and updated following the second consensus conference in Stockholm in 2005 (Fuchs-Buder et al., Acta Anaesthesiol Scand 2007, 51 , 789–808). In view of new devices and further development of monitoring technologies that emerged since then, (e.g., electromyography, three-dimensional acceleromyography, kinemyography) as well as novel compounds (e.g., sugammadex) a review and update of these recommendations became necessary. The intent of these revised guidelines is to continue to help clinical researchers to conduct high-quality work and advance the field by enhancing the standards, consistency, and comparability of clinical studies. There is growing awareness of the importance of consensus-based reporting standards in clinical trials and observational studies. Such global initiatives are necessary in order to minimize heterogeneous and inadequate data reporting and to improve clarity and comparability between different studies and study cohorts. Variations in definitions of endpoints or outcome variables can introduce confusion and difficulties in interpretation of data, but more importantly, it may preclude building of an adequate body of evidence to achieve reliable conclusions and recommendations. Clinical research in neuromuscular pharmacology and physiology is no exception. 相似文献
2.
3.
4.
Iris Cervenka Marie Al Rahmoun Yahya Mahamat-Saleh Agnès Fournier Marie-Christine Boutron-Ruault Gianluca Severi Saverio Caini Domenico Palli Reza Ghiasvand Marit B. Veierod Edoardo Botteri Anne Tjønneland Anja Olsen Renée T. Fortner Rudolf Kaaks Matthias B. Schulze Salvatore Panico Antonia Trichopoulou Clio Dessinioti Katerina Niforou Sabina Sieri Rosario Tumino Carlotta Sacerdote Bas Bueno-de-Mesquita Torkjel M. Sandanger Sandra Colorado-Yohar Maria J. Sánchez Leire Gil Majuelo Leila Lujan-Barroso Eva Ardanaz Susana Merino Karolin Isaksson Salma Butt Ingrid Ljuslinder Malin Jansson Ruth C. Travis Kay-Tee Khaw Elisabete Weiderpass Laure Dossus Sabina Rinaldi Marina Kvaskoff 《International journal of cancer. Journal international du cancer》2020,146(12):3267-3280
Evidence suggests an influence of sex hormones on cutaneous melanoma risk, but epidemiologic findings are conflicting. We examined the associations between use of oral contraceptives (OCs) and menopausal hormone therapy (MHT) and melanoma risk in women participating in the European Prospective Investigation into Cancer and Nutrition (EPIC). EPIC is a prospective cohort study initiated in 1992 in 10 European countries. Information on exogenous hormone use at baseline was derived from country-specific self-administered questionnaires. We used Cox proportional hazards regression models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Over 1992–2015, 1,696 melanoma cases were identified among 334,483 women, whereof 770 cases among 134,758 postmenopausal women. There was a positive, borderline-significant association between OC use and melanoma risk (HR = 1.12, 95% CI = 1.00–1.26), with no detected heterogeneity across countries (phomogeneity = 0.42). This risk increased linearly with duration of use (ptrend = 0.01). Among postmenopausal women, ever use of MHT was associated with a nonsignificant increase in melanoma risk overall (HR = 1.14, 95% CI = 0.97–1.43), which was heterogeneous across countries (phomogeneity = 0.05). Our findings do not support a strong and direct association between exogenous hormone use and melanoma risk. In order to better understand these relations, further research should be performed using prospectively collected data including detailed information on types of hormone, and on sun exposure, which may act as an important confounder or effect modifier on these relations. 相似文献
5.
6.
7.
8.
9.
10.